|
Symbol Name ID |
Msh2
mutS homolog 2 MGI:101816 |
| Darker colors indicate more annotations |
| Human Phenotypes | Pituitary adenoma |
Plexiform neurofibroma |
Astrocytoma |
Pleomorphic xanthoastrocytoma |
Ependymoma |
Glioblastoma multiforme |
Oligodendroglioma |
Agenesis of corpus callosum |
Gray matter heterotopia |
Benign neoplasm of the central nervous system |
Medulloblastoma |
Neuroblastoma |
Abnormal pyramidal sign |
Hemiplegia/hemiparesis |
Increased intracranial pressure |
Abnormality of speech or vocalization |
Dysarthria |
Dysgraphia |
Depression |
Irritability |
Disturbed sensory perception |
Anxiety |
Hallucinations |
Atypical behavior |
Attention deficit hyperactivity disorder |
Memory impairment |
Dyskinesia |
Gait disturbance |
Migraine |
Developmental regression |
Seizure |
Paresthesia |
| Disease(s) Associated with MSH2 | ||||||||||||||||||||||||||||||||
| Lynch syndrome | ||||||||||||||||||||||||||||||||
| mismatch repair cancer syndrome |
| Mouse Phenotypes | increased brain tumor incidence |
|
| Availability | Mouse Genotype | |
| Msh2tm1Htr/Msh2tm1Htr | ||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|
|
||
Analysis Tools